Incap Corporation:
22.2.2021 07:25:40 CET | Globenewswire | Press release
Incap Corporation Stock Exchange Release 19 February 2021 at 5.00 p.m. (EET)
Inside information
Incap increases its operating profit estimate for 2020
Incap Corporation estimates that its revenue for 2020 will be approximately EUR 106.5 million and the operating profit (EBIT) approximately EUR 12.6 million.
Previously the company estimated that its revenue for 2020 will be approximately EUR 105–107 million and the operating profit (EBIT) approximately EUR 10.5–11.5 million.
Incap’s Financial Statements Release for 2020 will be published on 24 February 2021.
INCAP CORPORATION
For additional information, please contact:
Otto Pukk, President and CEO, tel. +372 508 0798
DISTRIBUTION
Nasdaq Helsinki Ltd
Main media
www.incapcorp.com
INCAP IN BRIEF
Incap Corporation is a trusted partner and full-service provider in Electronics Manufacturing Services. As a global EMS company Incap supports customers ranging from large multinationals and mid-sized companies to small start-ups in their complete manufacturing value chain. Incap offers state-of-the-art technology backed up by an entrepreneurial culture and highly qualified personnel. The company has operations in Finland, Estonia, India, Slovakia, the UK and Hong Kong and employs approximately 1,900 people. Incap’s share has been listed on Nasdaq Helsinki Ltd stock exchange since 1997.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ISS World Services A/S31.3.2026 07:01:44 CEST | Press release
ISS extends major contract with large global customer
iHerb Holdings, Inc.31.3.2026 07:00:00 CEST | Press release
iHerb Appoints Andreas Baller as General Manager for Europe
dsm-firmenich31.3.2026 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
Sanofi Winthrop Industrie31.3.2026 07:00:00 CEST | Press release
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
Tenaris SA31.3.2026 02:35:40 CEST | Press release
Tenaris Files its 2025 Annual Report and its Annual Report on Form 20-F
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
